GLIMEPIRIDE 0.5mg. IP + METFORMIN 500mg. IP

Belongs to a class of medicines called anti-diabetic drugs used in the treatment of type 2 diabetes. (Rakesh Kumar Sahay, 2020) Lowers blood glucose levels in patients with Type 2 diabetes with comorbidities like hypertension, dyslipidemia, and diabetes complications. (Rakesh Kumar Sahay, 2020) Improves insulin sensitivity and enhances the body's response to insulin. (Rakesh Kumar Sahay, 2020) Helps lower blood sugar by promoting insulin secretion from the pancreas. Effectively reduces fasting plasma glucose, post-prandial glucose and glycosylated haemoglobin levels in patients with type 2 diabetes mellitus. (Abdul Basit, 2012) The preferred choice for the management of diabetes across all age groups. (Rakesh Kumar Sahay, 2020) A safe, effective, and cost-effective solution for managing type 2 diabetes. (Rakesh Kumar Sahay, 2020) An appropriate therapeutic option for managing patients in the early stages of type 2 diabetes mellitus. (George, 2015)